MONUROL

This brand name is authorized in United States. It is also authorized in Canada, Ecuador, Hong Kong SAR China, Israel, Singapore, Spain, Turkey.

Active ingredients

The drug MONUROL contains one active pharmaceutical ingredient (API):

1	Fosfomycin UNII 7FXW6U30GY - FOSFOMYCIN TROMETHAMINE
	Fosfomycin exerts a bactericidal effect on proliferating pathogens by preventing the enzymatic synthesis of the bacterial cell wall. Fosfomycin inhibits the first stage of intracellular bacterial cell wall synthesis by blocking peptidoglycan synthesis.
	Read more about Fosfomycin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MONUROL Granules for oral solution	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01XX01	Fosfomycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XX Other antibacterials
Discover more medicines within J01XX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02240335
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	1293-MEE-0815
ES	Centro de información online de medicamentos de la AEMPS	76799
HK	Department of Health Drug Office	43159
IL	מִשְׂרַד הַבְּרִיאוּת	3611
SG	Health Sciences Authority	11013P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699569240266
US	FDA, National Drug Code	0456-4300